Fabio Rigat, PhD in

Fabio Rigat, PhD

Critic · DISC type C
Executive Director, Oncology Biometrics, GI/GU/GYN Strategy Head at AstraZeneca
📍 Cambridge, England, United Kingdom

Fabio Rigat is the Executive Director of Oncology Biometrics at AstraZeneca, where he leads the strategy for late-stage GI, GU, and GYN cancer trials. A Duke University PhD, he has a deep background in statistical innovation and Bayesian modeling, frequently publishing on advanced methods for clinical trial design to advance new medicines.

Originally from Italy, Fabio is multilingual, speaking fluent Italian, English, and Portuguese. He has an extensive background in academia as an assistant professor and postdoctoral fellow before transitioning to the pharmaceutical industry. Before pursuing his PhD, he completed mandatory military service in Italy.

Unique fact: He is fluent in three languages (Italian, English, and Portuguese) and has intermediate proficiency in Spanish.

Read the full overview →
Experience
21 Years
Current Role
Executive Director, Oncology Biometrics, GI/GU/GYN Strategy Head
Job Level
Senior
Location
Cambridge, England, United Kingdom
Personality Overview

How Fabio shows up

Critic
Objective Thinker
ROI Driven

It is very likely that they will negotiate pricing or other important terms. They like to do things independently and don’t look for support from others. They choose to analyze logically and value facts to emotions.

Priorities

Topics Fabio cares about

Bayesian Trial Design
His PhD focused on Bayesian models, and he continues to publish on the topic, including a 2023 paper on leveraging external evidence for clinical trial design.
Oncology Strategy
As strategy head for GI/GU/GYN cancers at AstraZeneca, he is responsible for the design and execution of pivotal late-stage clinical trials.
+5 more topics Login to view topics
Career

Work history

1-2026
Executive Director, Oncology Biometrics, GI/GU/GYN Strategy Head
AstraZeneca
6-2022
Executive Director, GI Strategy Head, Late Oncology Statistics
AstraZeneca
11-2019 - 6-2022
UK head, Oncology Statistics and Decision Sciences
The Janssen Pharmaceutical Companies of Johnson & Johnson
9-2017 - 10-2019
Statistics Director, Oncology
GSK
9-2015 - 9-2017
Director, Statistical Innovation Group and then Advanced Biostatistics and Data Analytics Group
GSK
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2000 - 2004
Doctor of Philosophy (Ph.D.)
Duke University
1994 - 1999
Bachelor of Science (BSc)
Universita'di Pavia (BSc Economics, 1999)
Social presence
in
Behavioral profile

DISC profile (public)

C

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other AstraZeneca Employees

Explore more public profiles from related professionals.

Vijay Kamal Ahuja
Vijay Kamal Ahuja
Senior Scientist
AstraZeneca
 Marta Mazelanik
Marta Mazelanik
Associate Director, Analytics Data Preparation
AstraZeneca
 Gabriela Sawczuk
Gabriela Sawczuk
Global Clinical Solutions Manager
AstraZeneca
 Jerry Valentine CPA,MS-DIM
Jerry Valentine CPA,MS-DIM
Senior Director Commercial Innovation
AstraZeneca

More profiles

Discover additional public profiles from our index.

Xoel Rodríguez Arias
Xoel Rodríguez Arias
Especialista en logística
Aceites Abril S.L.
 syed parvez
syed parvez
Human Resources Executive
Decisions
 Wayne McNeil
Wayne McNeil
Executive Vice President : People & Organisation
XP Power
 Katie Frisby
Katie Frisby
HR Business Partner
ABF Business Technology Services
Unlock the full playbookSee exactly how to sell to Fabio. Free, 10 seconds.